Pharmacokinetics of Ceftaroline in a Preterm Infant With Methicillin-Resistant Staphylococcus Aureus Pneumonia.
Publication
, Journal Article
Salerno, SN; Bernhardt, J; Laughon, M; Jhaveri, R; Massaro, M; Gonzalez, D
Published in: J Pediatric Infect Dis Soc
December 3, 2018
We report here the first pharmacokinetic-pharmacodynamic relationship for ceftaroline in a preterm infant born at <28 weeks' gestational age who was given ceftaroline (8.5 mg/kg every 8 hours) for pneumonia attributable to methicillin-resistant Staphyloccocus aureus. This dose of ceftaroline was adequate to achieve the pharmacodynamic endpoint associated with efficacy for methicillin-resistant Staphyloccocus aureus.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Pediatric Infect Dis Soc
DOI
EISSN
2048-7207
Publication Date
December 3, 2018
Volume
7
Issue
4
Start / End Page
342 / 345
Location
England
Related Subject Headings
- Rifampin
- Pneumonia, Staphylococcal
- Methicillin-Resistant Staphylococcus aureus
- Infant, Premature, Diseases
- Infant, Premature
- Infant, Newborn
- Humans
- Female
- Fatal Outcome
- Drug Therapy, Combination
Citation
APA
Chicago
ICMJE
MLA
NLM
Salerno, S. N., Bernhardt, J., Laughon, M., Jhaveri, R., Massaro, M., & Gonzalez, D. (2018). Pharmacokinetics of Ceftaroline in a Preterm Infant With Methicillin-Resistant Staphylococcus Aureus Pneumonia. J Pediatric Infect Dis Soc, 7(4), 342–345. https://doi.org/10.1093/jpids/pix084
Salerno, Sara N., Janice Bernhardt, Matthew Laughon, Ravi Jhaveri, Matthew Massaro, and Daniel Gonzalez. “Pharmacokinetics of Ceftaroline in a Preterm Infant With Methicillin-Resistant Staphylococcus Aureus Pneumonia.” J Pediatric Infect Dis Soc 7, no. 4 (December 3, 2018): 342–45. https://doi.org/10.1093/jpids/pix084.
Salerno SN, Bernhardt J, Laughon M, Jhaveri R, Massaro M, Gonzalez D. Pharmacokinetics of Ceftaroline in a Preterm Infant With Methicillin-Resistant Staphylococcus Aureus Pneumonia. J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):342–5.
Salerno, Sara N., et al. “Pharmacokinetics of Ceftaroline in a Preterm Infant With Methicillin-Resistant Staphylococcus Aureus Pneumonia.” J Pediatric Infect Dis Soc, vol. 7, no. 4, Dec. 2018, pp. 342–45. Pubmed, doi:10.1093/jpids/pix084.
Salerno SN, Bernhardt J, Laughon M, Jhaveri R, Massaro M, Gonzalez D. Pharmacokinetics of Ceftaroline in a Preterm Infant With Methicillin-Resistant Staphylococcus Aureus Pneumonia. J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):342–345.
Published In
J Pediatric Infect Dis Soc
DOI
EISSN
2048-7207
Publication Date
December 3, 2018
Volume
7
Issue
4
Start / End Page
342 / 345
Location
England
Related Subject Headings
- Rifampin
- Pneumonia, Staphylococcal
- Methicillin-Resistant Staphylococcus aureus
- Infant, Premature, Diseases
- Infant, Premature
- Infant, Newborn
- Humans
- Female
- Fatal Outcome
- Drug Therapy, Combination